Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Cancer Society
Anti-inflammatory drugs may mask prostate cancer marker
September 23rd, 2008
Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications. That is the conclusion of a new study in the October 15, 2008 issue of CANCER, a peer reviewed journal of the American Cancer Society. Chronic inflammation has been linked to many different types of malignancies, including prostate cancer. Researchers suspect that inflammation associated with prostate cancer may occur through a variety of mechanisms such as infection, hormonal changes, physical trauma,...
Source: Cancer Weekly (2008-09-23)
|
